449
Views
0
CrossRef citations to date
0
Altmetric
Review Articles

Posterior Herpetic Uveitis: A Comprehensive Review

, MD, , MD, , MD, , MD, , MDORCID Icon, , MD & , MD show all
Pages 1461-1472 | Received 11 Oct 2022, Accepted 30 May 2023, Published online: 26 Jun 2023

References

  • Whitley RJ, Roizman B. Herpes simplex virus infections. Lancet. 2001;357(9267):1513–1518. doi:10.1016/S0140-6736(00)04638-9.
  • Gershon AA, Breuer J, Cohen JI, et al. Varicella zoster virus infection. Nat Rev Dis Primers. 2015;1(1):1. doi:10.1038/NRDP.2015.16.
  • Steiner I, Kennedy PG, Pachner AR. The neurotropic herpes viruses: herpes simplex and varicella-zoster. Lancet Neurol. 2007;6(11):1015–1028. doi:10.1016/S1474-4422(07)70267-3.
  • James C, Harfouche M, Welton NJ, et al. Herpes simplex virus: global infection prevalence and incidence estimates, 2016. Bull World Health Organ. 2020;98(5):315–329. doi:10.2471/BLT.19.237149.
  • Wharton M. The epidemiology of varicella-zoster virus infections. Infect Dis Clin North Am. 1996;10(3):571–581. doi:10.1016/S0891-5520(05)70313-5.
  • Lopez AS, Zhang J, Marin M. Epidemiology of varicella during the 2-dose varicella vaccination program - United States, 2005-2014. MMWR Morb Mortal Wkly Rep. 2016;65(34):902–905. doi:10.15585/MMWR.MM6534A4.
  • Marin M, Marti M, Kambhampati A, Jeram SM, Seward JF. Global varicella vaccine effectiveness: a meta-analysis. Pediatrics. 2016;137(3). doi:10.1542/PEDS.2015-3741.
  • Zhu S, Viejo-Borbolla A. Pathogenesis and virulence of herpes simplex virus. Virulence. 2021;12(1):2670–2702. doi:10.1080/21505594.2021.1982373.
  • Schuler S, Brunner M, Bernauer W. Rituximab and acute retinal necrosis in a patient with scleromalacia and rheumatoid arthritis. Ocul Immunol Inflamm. 2016;24(1):96–98. doi:10.3109/09273948.2014.999377.
  • Miserocchi E, Waheed NK, Dios E, et al. Visual outcome in herpes simplex virus and varicella zoster virus uveitis: a clinical evaluation and comparison. Ophthalmology. 2002;109(8):1532–1537. doi:10.1016/S0161-6420(02)01113-2.
  • Bodaghi B, Rozenberg F, Cassoux N, Fardeau C, LeHoang P. Nonnecrotizing herpetic retinopathies masquerading as severe posterior uveitis. Ophthalmology. 2003;110(9):1737–1743. doi:10.1016/S0161-6420(03)00580-3.
  • Wickremasinghe SS, Stawell R, Lim L, Pakrou N, Zamir E. Non-necrotizing herpetic vasculitis. Ophthalmology. 2009;116(2):361–361.e2. doi:10.1016/J.OPHTHA.2008.09.043.
  • Yoser SL, Forster DJ, Rao NA. Systemic viral infections and their retinal and choroidal manifestations. Surv Ophthalmol. 1993;37(5):313–352. doi:10.1016/0039-6257(93)90064-E.
  • Wensing B, de Groot-Mijnes JDF, Rothova A. Necrotizing and nonnecrotizing variants of herpetic uveitis with posterior segment involvement. Arch Ophthalmol. 2011;129(4):403–408. doi:10.1001/ARCHOPHTHALMOL.2010.313.
  • Holland GN. Standard diagnostic criteria for the acute retinal necrosis syndrome. executive committee of the American uveitis society. Am J Ophthalmol. 1994;117(5):663–666. doi:10.1016/S0002-9394(14)70075-3.
  • Bergstrom R, Tripathy K. Acute retinal Necrosis. StatPearls. https://pubmed.ncbi.nlm.nih.gov/29262034/0. Published 2023. Accessed May 11, 2023.
  • Unilateral acute uveitis with retinal periarteritis and detachment | CiNii Research. https://cir.nii.ac.jp/crid/1570854174924540032. Accessed June 7, 2022.
  • Young NJA, Bird AC. Bilateral acute retinal necrosis. Br J Ophthalmol. 1978;62(9):581–590. doi:10.1136/BJO.62.9.581.
  • Zhao XY, Meng LH, Zhang WF, Wang DY, Chen YX. Retinal detachment after acute retinal necrosis and the efficacies of different interventions: a systematic review and metaanalysis. Retina. 2021;41(5):965–978. doi:10.1097/IAE.0000000000002971.
  • Muthiah MN, Michaelides M, Child CS, Mittchell SM. Acute retinal necrosis: a national population-based study to assess the incidence, methods of diagnosis, treatment strategies and outcomes in the UK. Br J Ophthalmol. 2007;91(11):1452–1455. doi:10.1136/BJO.2007.114884.
  • Cochrane TF, Silvestri G, McDowell C, Foot B, McAvoy CE. Acute retinal necrosis in the United Kingdom: results of a prospective surveillance study. Eye (Lond). 2012;26(3):370–378. doi:10.1038/EYE.2011.338.
  • Classification criteria for acute retinal necrosis syndrome. Am J Ophthalmol. 2021;228:237–244. doi:10.1016/J.AJO.2021.03.057.
  • Nishiyama T, Tsujinaka H, Mizusawa Y, Ueda T, Ogata N. Acute retinal necrosis in a patient on immunosuppressive treatment for COVID-19 pneumonia: a case report. BMC Ophthalmol. 2022;22(1). doi:10.1186/S12886-022-02692-5.
  • Culbertson WW, Blumenkranz MS, Pepose JS, Stewart JA, Curtin VT. Varicella zoster virus is a cause of the acute retinal necrosis syndrome. Ophthalmology. 1986;93(5):559–569. doi:10.1016/S0161-6420(86)33701-1.
  • Ganatra JB, Chandler D, Santos C, Kuppermann B, Margolis TP. Viral causes of the acute retinal necrosis syndrome. Am J Ophthalmol. 2000;129(2):166–172. doi:10.1016/S0002-9394(99)00316-5.
  • Roy R, Pal BP, Mathur G, Rao C, Das D, Biswas J. Acute retinal necrosis: clinical features, management and outcomes–a 10 year consecutive case series. Ocul Immunol Inflamm. 2014;22(3):170–174. doi:10.3109/09273948.2013.819928.
  • Takase H, Okada AA, Goto H, et al. Development and validation of new diagnostic criteria for acute retinal necrosis. Jpn J Ophthalmol. 2015;59(1):14–20. doi:10.1007/S10384-014-0362-0.
  • Pichi F, Curi ALL, Vasconcelos-Santos DV, et al. Optical coherence tomography findings in infectious posterior uveitis. Ocul Immunol Inflamm. 2022;30(3):652–663. doi:10.1080/09273948.2022.2032197. Published online 2022.
  • Invernizzi A, Agarwal AK, Ravera V, et al. Comparing optical coherence tomography findings in different aetiologies of infectious necrotising retinitis. Br J Ophthalmol. 2018;102(4):433–437. doi:10.1136/BJOPHTHALMOL-2017-310210.
  • Butler NJ, Moradi A, Salek SS, et al. Acute retinal necrosis: presenting characteristics and clinical outcomes in a cohort of polymerase chain reaction-positive patients. Am J Ophthalmol. 2017;179:179–189. doi:10.1016/J.AJO.2017.05.006.
  • Schoenberger SD, Kim SJ, Thorne JE, et al. Diagnosis and treatment of acute retinal necrosis: a report by the American Academy of Ophthalmology. Ophthalmology. 2017;124(3):382–392. doi:10.1016/J.OPHTHA.2016.11.007.
  • Bernheim D, Germi R, Labetoulle M, Romanet JP, Morand P, Chiquet C. Time profile of viral DNA in aqueous humor samples of patients treated for varicella-zoster virus acute retinal necrosis by use of quantitative real-time PCR. J Clin Microbiol. 2013;51(7):2160–2166. doi:10.1128/JCM.00294-13.
  • Takase H, Goto H, Namba K, et al. Clinical characteristics, management, and factors associated with poor visual prognosis of acute retinal necrosis. Ocul Immunol Inflamm. 2022;30(1):48–53. doi:10.1080/09273948.2020.1789179.
  • Forster DJ, Dugel PU, Frangieh GT, Liggett PE, Rao NA. Rapidly progressive outer retinal necrosis in the acquired immunodeficiency syndrome. Am J Ophthalmol. 1990;110(4):341–348. doi:10.1016/S0002-9394(14)77012-6.
  • Greven CM, Ford J, Stanton C, et al. Progressive outer retinal necrosis secondary to varicella zoster virus in acquired immune deficiency syndrome. Retina. 1995;15(1):14–20. doi:10.1097/00006982-199515010-00003.
  • Tseng CC, Chen SN, Hwang JF, Lin CJ, Chen HS. Progressive outer retinal necrosis associated with occlusive vasculitis in acquired immunodeficiency syndrome. J Formos Med Assoc. 2015;114(5):469–472. doi:10.1016/J.JFMA.2012.04.005.
  • Margolis TP, Lowder CY, Holland GN, et al. Varicella-zoster virus retinitis in patients with the acquired immunodeficiency syndrome. Am J Ophthalmol. 1991;112(2):119–131. doi:10.1016/S0002-9394(14)76690-5.
  • Pavesio CE, Mitchell SM, Barton K, Schwartz SD, Towler HMA, Lightman S. Progressive outer retinal necrosis (PORN) in AIDS patients: a different appearance of varicella-zoster retinitis. Eye (Lond). 1995;9(Pt 3):271–276. doi:10.1038/EYE.1995.53.
  • Wu XN, Lightman S, Tomkins-Netzer O. Viral retinitis: diagnosis and management in the era of biologic immunosuppression: a review. Clin Exp Ophthalmol. 2019;47(3):381–395. doi:10.1111/CEO.13500.
  • RE E, GN H, TP M, et al. The progressive outer retinal necrosis syndrome. A variant of necrotizing herpetic retinopathy in patients with AIDS. Ophthalmology. 1994;101(9):158–168. doi:10.1016/S0161-6420(94)31142-0.
  • Kalpoe JS, van Dehn CE, Bollemeijer JG, et al. Varicella zoster virus (VZV)-related progressive outer retinal necrosis (PORN) after allogeneic stem cell transplantation. Bone Marrow Transplant. 2005;36(5):467–469. doi:10.1038/sj.bmt.1705085.
  • Moorthy RS, Weinberg DV, Teich SA, et al. Management of varicella zoster virus retinitis in AIDS. Br J Ophthalmol. 1997;81(3):189–194. doi:10.1136/BJO.81.3.189.
  • van den HornGJ, Meenken C, Troost D. Association of progressive outer retinal necrosis and varicella zoster encephalitis in a patient with AIDS. British J Ophthalmol. 1996;80(11):982–985. doi:10.1136/BJO.80.11.982.
  • Jeske DN. The progressive outer retinal necrosis syndrome: a variant of necrotizing herpetic retinopathy in patients with AIDS. Ophthalmology. 1994;101(9):1488–1502. doi:10.1016/S0161-6420(94)31142-0.
  • Almony A, Dhalla MS, Feiner L, Shah GK. Macular optical coherence tomography findings in progressive outer retinal necrosis. Can J Ophthalmol. 2007;42(6):881. doi:10.3129/I07-171.
  • Yeh S, Wong WT, Weichel ED, Lew JC, Chew EY, Nussenblatt RB. Fundus autofluorescence and OCT in the management of progressive outer retinal necrosis. Ophthalmic Surg Lasers Imaging Retina. 2010;41(3):1–4. doi:10.3928/15428877-20100216-14. Published online March 22.
  • Walton RC, Byrnes GA, Chan CC, Nussenblatt RB. Fluorescein angiography in the progressive outer retinal necrosis syndrome. Retina. 1996;16(5):393–398. doi:10.1097/00006982-199616050-00005.
  • Scott UI, Luu MK, Davis LJ. Intravitreal antivirals in the management of patients with acquired immunodeficiency syndrome with progressive outer retinal necrosis - PubMed. Arch Ophthalmol. 2002;120:1219–1222.
  • Spaide RF, Martin DF, Teich SA, Katz A, Toth I. Successful treatment of progressive outer retinal necrosis syndrome. Retina. 1996;16(6):479–487. doi:10.1097/00006982-199616060-00003.
  • Perez-Blazquez E, Traspas R, Marin IM, Montero M. Intravitreal ganciclovir treatment in progressive outer retinal necrosis. Am J Ophthalmol. 1997;124(3):418–421. doi:10.1016/S0002-9394(14)70845-1.
  • Ciulla TA, Rutledge BK, Morley MG, Duker JS. The progressive outer retinal necrosis syndrome: successful treatment with combination antiviral therapy. Ophthalmic Surg Lasers Imaging. 1998;29(3):198–206. doi:10.3928/1542-8877-19980301-05.
  • Gore DM, Gore SK, Visser L. Progressive outer retinal necrosis: outcomes in the intravitreal era. Arch Ophthalmol. 2012;130(6):700–706. doi:10.1001/ARCHOPHTHALMOL.2011.2622.
  • Kuo YH, Yip Y, Chen SN. Retinal vasculitis associated with chickenpox. Am J Ophthalmol. 2001;132(4):584–585. doi:10.1016/S0002-9394(01)01058-3.
  • Narayanan S, Gopalakrishnan M, Giridhar A, Anthony E. Varicella zoster-related occlusive retinal vasculopathy–a rare presentation. Ocul Immunol Inflamm. 2016;24(2):227–230. doi:10.3109/09273948.2014.938759.
  • Albert K, Masset M, Bonnet S, Willermain F, Caspers L. Long-term follow-up of herpetic non-necrotizing retinopathy with occlusive retinal vasculitis and neovascularization. J Ophthalmic Inflamm Infect. 2015;5(1). doi:10.1186/S12348-015-0038-Z.
  • Rafailidis PI, Mourtzoukou EG, Varbobitis IC, Falagas ME. Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review. Virol J. 2008;5(1):5. doi:10.1186/1743-422X-5-47.
  • Jabs DA, Ahuja A, van Natta M, Lyon A, Srivastava S, Gangaputra S. Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: five-year outcomes. Ophthalmology. 2010;117(11):2152–2161.e2. doi:10.1016/J.OPHTHA.2010.03.031.
  • Vertes D, Snyers B, de Potter P. Cytomegalovirus retinitis after low-dose intravitreous triamcinolone acetonide in an immunocompetent patient: a warning for the widespread use of intravitreous corticosteroids. Int Ophthalmol. 2010;30(5):595–597. doi:10.1007/S10792-010-9404-X.
  • Crowe SM, Carlin JB, Stewart KI, Lucas CR, Hoy JF. Predictive value of CD4 lymphocyte numbers for the development of opportunistic infections and malignancies in HIV-infected persons. J Acquir Immune Defic Syndr (1988). 1991;4(8):770–776. https://pubmed.ncbi.nlm.nih.gov/1677419/. Accessed April 25, 2022.
  • Lee JH, Agarwal A, Mahendradas P, et al. Viral posterior uveitis. Surv Ophthalmol. 2017;62(4):404–445. doi:10.1016/J.SURVOPHTHAL.2016.12.008.
  • Steffen J, Rice J. Cytomegalovirus: clinical features and management. Community Eye Health. 2020;33(108):79–80. https://pubmed.ncbi.nlm.nih.gov/32395032/. Accessed May 9, 2022.
  • Pathanapitoon K, Tesavibul N, Choopong P, et al. Clinical manifestations of cytomegalovirus-associated posterior uveitis and panuveitis in patients without human immunodeficiency virus infection. JAMA Ophthalmol. 2013;131(5):638–645. doi:10.1001/JAMAOPHTHALMOL.2013.2860.
  • Arevalo JF, Garcia RA, Mendoza AJ. High-dose (5000-μg) intravitreal ganciclovir combined with highly active antiretroviral therapy for cytomegalovirus retinitis in HIV-infected patients in Venezuela. Eur J Ophthalmol. 2005;15(5):610–618. doi:10.1177/112067210501500512.
  • Jabs DA, Belfort R, Bodaghi B, et al. Classification criteria for cytomegalovirus retinitis. Am J Ophthalmol. 2021;228:245–254. doi:10.1016/J.AJO.2021.03.051.
  • Mansour AM, Li HK. Cytomegalovirus optic neuritis: characteristics, therapy and survival. Ophthalmologica. 1995;209(5):260–266. doi:10.1159/000310627.
  • Vrabec TR. Posterior segment manifestations of HIV/AIDS. Surv Ophthalmol. 2004;49(2):131–157. doi:10.1016/J.SURVOPHTHAL.2003.12.008.
  • Baldassano V, Dunn JP, Feinberg J, Jabs DA. Cytomegalovirus retinitis and low CD4+ T-lymphocyte counts. N Engl J Med. 1995;333(10):670–670. doi:10.1056/NEJM199509073331019.
  • Schneider EW, Elner SG, van Kuijk FJ, et al. Chronic retinal necrosis: cytomegalovirus necrotizing retinitis associated with panretinal vasculopathy in non-HIV patients. Retina. 2013;33(9):1791–1799. doi:10.1097/IAE.0B013E318285F486.
  • Port AD, Orlin A, Kiss S, Patel S, D’Amico DJ, Gupta MP. Cytomegalovirus retinitis: a review. J Ocul Pharmacol Ther. 2017;33(4):224–234. doi:10.1089/JOP.2016.0140.
  • Nguyen QD, Kempen JH, Bolton SG, Dunn JP, Jabs DA. Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis after highly active antiretroviral therapy. Am J Ophthalmol. 2000;129(5):634–639. doi:10.1016/S0002-9394(00)00356-1.
  • Silverstien BE, Conrad D, Margolis TP, Wong IG. Cytomegalovirus-associated acute retinal necrosis syndrome. Am J Ophthalmol. 1997;123(2):257–258. doi:10.1016/S0002-9394(14)71046-3.
  • Holland GN, Vaudaux JD, Shiramizu KM, et al. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000). Am J Ophthalmol. 2008;145(1):12–22.e10. doi:10.1016/J.AJO.2007.09.040.
  • Suryawanshi A, Veiga-Parga T, Rajasagi NK, et al. Role of IL-17 and Th17 cells in herpes simplex virus-induced corneal immunopathology. J Immunol. 2011;187(4):1919–1930. doi:10.4049/JIMMUNOL.1100736.
  • Rajasagi NK, Rouse BT. The role of T cells in herpes stromal keratitis. Front Immunol. 2019;10(MAR). doi:10.3389/fimmu.2019.00512.
  • Egbert PR, Pollard RB, Gallagher JG, Merigan TC. Cytomegalovirus retinitis in immunosuppressed hosts. II. Ocular manifestations. Ann Int Med. 1980;93(5):664–670. doi:10.7326/0003-4819-93-5-664.
  • Palestine AG, Palestine AG. Clinical aspects of cytomegalovirus retinitis. Rev Infect Dis. 1988;10(Suppl 3):S515–S521. doi:10.1093/CLINIDS/10.SUPPLEMENT_3.S515.
  • Newman H, Gooding C. Viral ocular manifestations: a broad overview. Rev Med Virol. 2013;23(5):281–294. doi:10.1002/RMV.1749.
  • Harper TW, Miller D, Schiffman JC, Davis JL. Polymerase chain reaction analysis of aqueous and vitreous specimens in the diagnosis of posterior segment infectious uveitis. Am J Ophthalmol. 2009;147(1):140–147.e2. doi:10.1016/J.AJO.2008.07.043.
  • Ng Ming Choo E, Othman O, Lim ALS. An unusual cytomegalovirus ocular manifestation in a non-HIV patient. Cureus. 2022;14(2). doi:10.7759/CUREUS.21947.
  • Park JJ, Pavesio C. Prophylactic laser photocoagulation for acute retinal necrosis. Does it raise more questions than answers? Br J Ophthalmol. 2008;92(9):1161–1162. doi:10.1136/BJO.2008.147181.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.